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Hairpin DNA ends are evolutionarily conserved intermediates in DNA recombination. The hairpin struc-
tures present on the ends of the adeno-associated virus (AAV) genome are substrates for recombination that
give rise to persistent circular and concatemeric DNA episomes through intramolecular and intermolecular
recombination, respectively. We have developed circularization-dependent and orientation-specific self-com-
plementary AAV (scAAV) vectors as a reporter system to examine recombination events involving distinct
hairpin structures, i.e., closed versus open hairpins. The results suggest that intramolecular recombination
(circularization) is far more efficient than intermolecular recombination (concatemerization). Among all
possible combinations of terminal repeats (TRs) involved in intermolecular recombination, the closed-closed
TR structures are twice as efficient as the open-open TR substrates for recombination. In addition, both
intramolecular recombination and intermolecular recombination exhibit the common dependency on specific
DNA polymerases and topoisomerases. The circularization-dependent and orientation-specific scAAV vectors
can serve as an efficient and controlled system for the delivery of DNA structures that mimic mammalian
recombination intermediates and should be useful in assaying recombination in different experimental settings
as well as elucidating the molecular mechanism of recombinant AAV genome persistence.
Hairpin (HP) DNA structures are recombination interme-
diates in systems ranging from bacterial transposons to mam-
malian V(D)J recombination (for reviews, see references 8, 10,
and 11). The proteins that carry out the processing of terminal
HPs are evolutionarily conserved in bacteria, yeast, plants, and
animals (10, 12–14, 21). The linear single-strand DNA genome
of adeno-associated virus (AAV) forms similar HP structures
at its ends, through base-pairing of inverted terminal repeats
(TRs), and also undergoes extensive recombination, forming
DNA circles and concatemers after infection (17, 25, 31). Thus,
AAV provides a useful model for studying mammalian DNA
recombination involving HP structures.
Self-complementary AAV (scAAV) is a derivative of con-
ventional recombinant AAV which we have recently developed
as an enhanced-efficiency gene delivery vector (15). While con-
ventional single-stranded recombinant AAV (rAAV) requires
second-strand synthesis before genes can be expressed, scAAV
bypasses this step by delivering a duplex genome. This was
achieved by deleting a minor portion (28 bases of 145 bases) of
the sequence of one TR such that it no longer serves as a
replication origin but still forms the wild-type (wt) AAV TR
HP structure (16). Rolling HP replication from the remaining
wt TR creates single-stranded, dimeric inverted-repeat ge-
nomes, with the altered TR sequence situated in the middle of
the molecule and a wt TR at each end (see Fig. 1A, B, and C).
When the DNA is folded to a double-stranded molecule, a
closed HP end (C) is formed from the altered TR, and an open
end (O) from the two wt TRs (see Fig. 1C). The scAAV
genome not only mimics the structure of the single-stranded
rAAV genome after second-strand synthesis but also creates a
novel feature: controlled orientation of the coding sequences
with respect to the closed and open HPs (see Fig. 1C). These
unique features allowed us to devise a marker rescue system to
investigate the contributions of the HP structures to the rela-
tive frequencies of intramolecular and intermolecular recom-
bination. In addition, we were able to investigate the cellular
factors involved in TR HP recombination. In designing our
system, we employed a previously described orientation-non-
specific split-gene vector strategy (1, 6, 18, 23, 28, 33). For
intramolecular recombination, we engineered an orientation-
specific split-gene vector that would depend on circularization
for functional transgene expression (see Fig. 1A). For inter-
molecular recombination, we cloned two half-gene segments
into separate scAAV vectors with defined orientation of cod-
ing sequences with respect to the open and closed TR HP (see
Fig. 1B). Using these reagents, we were able to specifically
study the intramolecular recombination frequency between
closed and open TRs on the same genome as well as score
specific intermolecular recombination events between two split
vectors (i.e., closed-to-closed [C-C], open-to-open [O-O], and
closed-to-open [C-O] HP ends) by functional expression of the
transgene product (see Fig. 1B).
Among the novel findings we report are that the majority of
vector genomes undergo intramolecular recombination (circu-
larization) within 24 h. Preexisting free DNA 5 and 3 ends are
not required for intramolecular or intermolecular scAAV ge-
nome recombination, and recombination between C-C ge-
nome ends is preferred. Furthermore, both intramolecular and
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intermolecular recombinations require similar host cell factors,
such as DNA polymerases and topoisomerases. In addition to
the utility of scAAV as a general model for DNA recombina-
tion, the elucidation of the principles governing rAAV vector
recombination and persistence is important for its use as a
therapeutic vector in humans.
MATERIALS AND METHODS
Maintenance of cells. HeLa and 293 cells were grown in Dulbecco’s modified
Eagle’s medium supplemented with 10% heat-inactivated fetal bovine serum
(Sigma). C12 cells used for infectious centers assay (2, 38) were grown under the
same conditions as HeLa cells with the addition of 0.5 mg/ml G418 (Invitrogen).
Cells were grown at 37°C in a 5%-CO2 humidified incubator.
Plasmid constructs. The expression cassette of the split vectors and circular-
ization-dependent (scAAV-GFPcd) vector contain a cytomegalovirus promoter,
a green fluorescent protein (GFP) transgene split into a 5, left half (GFP-L) and
a 3, right half (GFP-R), and an hCG intron (29) inserted between GFP-L and
GFP-R, followed by a polyadenylation site after GFP-R. The GFP-L and GFP-R
fragments were PCR generated using primers containing restriction sites: GFP-
Ltop (Acc65I, MluI), 5GGTACCACGCGTCGTTACATAACTTACGGTAA;
GFP-Lbot (BglII), 5AGATCTTCTTACCTTCAGCTCGATGCGGTTCAC;
GFP-Rtop (PstI), 5CTGCAGGGCATCGACTTCAAGGAGGACGGCAACA;
and GFP-Rbot (SalI, MluI), 5GTCGACACGCGTTAAAAAACCTCCCACA
CCTCCC. GFP-Lbot also contained the 5 splice donor site of the intron. The
remainder of the hCG intron was amplified from pCMV-LacZ-Int (28) using the
following primers: IntKPTop (Acc65I, BglII), 5GGTACCAGATCTTCCG
GAGGGCCCCT; and IntKPBot (PstI), 5GCCCTGCAGGGTAACCGGA
CAAG. The GFP-L fragment or the intron plus GFP-R fragment were cloned in
both orientations into the AAV construct, pHpa7 (26), between HpaI and XbaI
by blunt-end ligation. Lambda phage MluI stuffer fragments of 956 bp and 1,256
bp were cloned into the MluI sites of GFP-L and GFP-R, respectively. To
generate the scAAV-GFPcd vector, the GFP-L fragment was placed downstream
of the GFP-R fragment and cloned into pHpa7 as above. As positive controls, the
intact expression cassette with intron was cloned into pHpa7 as above.
Viral production and characterization. Viruses were generated using the tri-
ple-transfection method as described previously (32). The virus was purified by
discontinuous iodixanol gradient separation and heparin chromatography (27).
Five independently prepared batches of split scAAV vectors, three purified
preparations and two cleared freeze/thaw lysates, were characterized by dot blot
hybridization and infectious center assay (2, 38) and tested for recombination.
The structure and orientation of the scAAV genomes were confirmed by alkaline
gel electrophoresis and Southern blotting of virion DNA digested with single-cut
restriction enzymes. Vector sequences were excised from the plasmid using
restriction enzymes to serve as size markers on Southern blots.
Recombination assays. Circularization assays were performed by infecting
cells at a low multiplicity of infection (MOI) with equal infectious units of
scAAV-GFPcd or the intact cassette vector. For concatemerization assays, equal
infectious units of L1 or L2 and R1 or R2 split scAAV vectors were coinfected
into HeLa, HEK 293, and CHOK1 cells at the indicated multiplicities for 3 to 4 h
and then replaced with fresh medium. Cells were harvested 24 h postinfection
(p.i.) and scored by fluorescence microscopy or by FACScan (Becton-Dickinson)
fluorescence-activated cell sorting as indicated.
Drug treatment. HeLa cells were treated with either 20 mM hydroxyurea
(HU), 10 g/ml aphidocolin (Aph), 1 M etoposide (Etopo), or 25 nM camp-
tothecin (CPT) (Sigma) 24 h prior to and during virus infection. The topoiso-
merase inhibitors (Etopo and CPT) were characterized on HeLa cells by a
dose-response curve to ensure that apoptosis was not induced at these concen-
trations. Virus was added in a minimal volume and left on the cells for 3 h. The
medium and unbound virus were removed and replaced with fresh medium
containing the same concentration of drug. Cells were harvested 24 h p.i., and
GFP expression was scored by FACScan (Becton-Dickinson).
FIG. 1. Orientation-specific split scAAV vectors and circulariza-
tion-dependent scAAV vectors. (A) Illustration of the circularization-
dependent scAAV vector (scAAVGFP-cd), which requires intramo-
lecular recombination between the closed and open end to express
GFP. (B) Illustration of the four combinations of split scAAV vectors
used in measuring concatemerization. The boxed areas represent the
specific combination of TRs required to generate a productive tem-
plate for gene expression. The combinations are designated as closed-
closed TRs (C-C), open-open (O-O), closed-open (C-O), and open-
closed (O-C). (C) Two scAAV vectors, GFP1 and GFP2, are
illustrated. Both serve as positive controls for comparison to the split
vectors in concatemerization and circularization recombination assays.
(D) Alkaline gel electrophoresis of undigested and single-cut viral
genomes (unique restriction enzyme recognition site indicated with a
vertical arrowhead). The undigested hairpinned virion DNA (V) is
twice the size of the fragment excised from digested plasmid (P) under
denaturing conditions. For determining the direction of the transgene
cassette, for example, digestion of the GFP2 genome (lane e) with the
single-cut enzyme, SacI, created fragments with 1.1 kb and 1.8 kb
which were not resolved (see arrow), while the same digest on the
GFP1 genome (lane f) created fragments with 3.4 kb and 0.7 kb (see
arrows), which could be resolved on the gel. The digested virion DNA
mobilities were consistent with the predicted sizes of fragments having
the hairpin at either the upstream or downstream end. Over 90% of
virion DNA was dimeric and orientation specific. a, L1; b, L2; c, R1; d,
R2; e, GFP2; f, GFP1; g, scAAVGFP-cd.
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RESULTS
A novel system for characterizing hairpin recombination.
We created a scAAV reporter system to measure the efficiency
of intramolecular and intermolecular recombination between
AAV terminal repeat HP structures, which mechanism in-
volves the utilization of free DNA ends (or generation of free
ends from a DNA strand) and strand processing, followed by
ligation to covalently join the DNA ends. The assay utilizes a
CMV-GFP cassette split into halves (5, left and 3, right half)
which can only be reconstituted by DNA recombination. An
intron sequence spanning the recombination junction allows
protein expression from the reconstituted gene regardless of
the recombination junction (Fig. 1).
The vector used to measure intramolecular recombination
(circularization) in this assay was made by situating the 5 half
of the GFP expression cassette at the right end and the 3 half
at the opposite end of the genome (Fig. 1A). Reconstitution of
gene expression will result from recombination between the
two ends of a single vector molecule or by joining two mole-
cules in the correct orientation. We established conditions (low
MOI) to preclude interactions between two molecules, such
that only circularization was measured (see Methods).
Similarly, for measurement of intermolecular recombina-
tion, separate scAAV vectors were constructed, carrying either
the 5 or the 3 half of the GFP cassettes (as described above)
in fixed orientation with respect to altered or wt terminal
repeats (Fig. 1B). This resulted in a total of four split-vector
substrates. In coinfections using different combinations of
these vector substrates, transgene expression is observed after
intermolecular recombination takes place between specific TR
substrates, designated closed-closed (C-C), open-open (O-O),
closed-open (C-O), and open-closed (O-C) (Fig. 1B). Two
control vectors that can lead to gene expression without the
requirement of DNA recombination were constructed with the
intact expression cassette (including the exogenous intron)
cloned in each orientation with respect to the viral open and
closed TR structures (Fig. 1C). Using these reagents, maxi-
mum levels of gene expression as well as potential influence of
orientation with respect to TR structures on GFP expression
could be measured.
The parent plasmids used to generate scAAV viral vectors
for this study have been described previously (26). To ensure
that the split and intact vector orientations were maintained
after vector production, purified virion DNA was extracted and
analyzed by alkaline agarose electrophoresis with and without
restriction digestion (Fig. 1D). In this analysis, all fragments
migrated with the correct mobility as expected in each con-
struct (Fig. 1D). The split-vector constructs were designated
L1 (5, left half of GFP with closed hairpin at downstream
end), L2 (5, left half of GFP with closed hairpin upstream),
R1, and R2, respectively. The two intact GFP control vectors
were identified as GFP1 and GFP2. The titer of each vector
was determined in terms of DNA-containing particles per ml
by dot blot, and infectious units (IU) per ml were determined
by infectious center assay (2, 38).
Circularization of vector genomes. Intramolecular recombi-
nation yielding a circular genome would utilize the closed and
open HP of a single DNA molecule. In order to measure only
intramolecular and not intermolecular recombination (con-
catemerization), a low MOI was used in these experiments (0.2
IU/cell or 0.5 IU/cell). Surprisingly, up to 97% of cells infected
with the scAAV-GFPcd vector resulted in GFP expression
compared to results with intact GFP vectors at the same MOI
24 h postinfection (Fig. 2A and 2B). This suggested that the
linear DNA forms of the infected genomes are not stable
intermediates and are rapidly converted to circles by recombi-
nation between the two HP substrates. In addition, the num-
bers of cells transduced by control intact vectors, GFP1 and
GFP2, were equivalent and not greatly influenced by the jux-
taposition of the transgene cassette relative to the open and
closed TRs. Since a hallmark of AAV genome persistence in
animals is the accumulation of a high-molecular-weight con-
catemeric DNA vector substrate, the requirement of TR HP
structures for such intermolecular recombination was explored.
Closed-end TR is preferred over open-end TR for rAAV
intermolecular recombination. A time course measuring inter-
molecular recombination using the orientation-specific split
vector pairwise combinations was performed at 10 IU per cell
in a 1:1 ratio at 13, 18, 24, 36, and 42 h p.i. (Fig. 3A). At all time
points, the C-C combination was scored as the most efficient
substrate, while O-O was least. Consistent with this observa-
tion, the frequency of joining C-O and O-C ends was always
intermediate (see Fig. 3 and Discussion regarding recombina-
tion probabilities). Recombination events plateau at 48 h p.i.,
FIG. 2. High efficiency of circularization of scAAV genomes and
dependence on host cell DNA polymerase and topoisomerases. HeLa
cells were infected with circularization-dependent (scAAVGFP-cd) or
control vectors (GFP2 and GFP1) at 0.2 IU/cell (A) or 0.5 IU/cell (B).
Drug treatments were the same as described in the legend to Fig. 4.
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suggesting that most of the substrate molecules were either no
longer available or were diluted as a result of cell division.
To test whether increased substrate concentrations influ-
enced intermolecular recombination or if the phenomenon was
unique to this cell type, we performed the assay at a higher
MOI (20 and 50 IU/cell/virus) in HeLa (Fig. 3B), HEK293, and
CHOK1 cells (data not shown). Again, the C-C intermolecular
recombination events were consistently twofold greater than
the O-O combination (Fig. 3B), with C-O and O-C scored as
intermediate (Fig. 3A and 3B). Analyses of intermolecular
recombination in HEK293 and CHOK1 cells were nearly iden-
tical to that for HeLa (data not shown), suggesting a general
preference for the closed HP as a recombination substrate. In
addition, the O-C and C-O combinations were functionally the
same, regardless of the transgene orientation (Fig. 1B). Based
on these observations, recombination could occur at either the
closed or the open TR HP structures, and preexisting free 5
and 3 DNA ends were not required, though free ends had to
be generated when utilizing closed DNA HP substrates during
recombination. Characterization of the DNA recombination
junctions directly by Southern analysis, PCR, or bacterial clon-
ing was inconclusive, due to low amounts of products, highly
GC-rich secondary structure (over 80%), and instability in
Escherichia coli (22, 34).
Inhibition of circularization by drug treatment. Based on
the above results, significant processing of vector DNA would
be required prior to recombination, i.e., nicking, unwinding,
and/or degradation of the closed HP and/or the open end.
Prior studies have determined that recombination between
AAV TRs results in nonhomogenous junctions with various
size deletions (4, 24, 35). Whether TR recombination involves
only breakage and rejoining of preexisting TR HP DNA sub-
strate or requires DNA synthesis is not clear. To further ex-
plore this, we assayed DNA recombination in the presence of
DNA synthesis and topoisomerases inhibitors.
Two different kinds of inhibitors were used to treat HeLa
cells 24 h before and during the infection with the scAAV-
GFPcd and control GFP vectors. HU inhibits host cell ribonu-
cleotide reductase and broadly inhibits DNA synthesis. As
shown in Fig. 2A, HU treatment completely abolished circu-
larization of scAAV-GFPcd but transduction of neither of the
control vectors was inhibited. In contrast, Aph specifically in-
hibits the cellular DNA polymerases , , and ε. While Aph
enhanced transduction with the control vectors, as we had
previously described (Fig. 2A.) (15), Aph treatment inhibited
the efficiency of scAAV-GFPcd to about threefold lower than
that in the untreated cells. These results suggest that host cell
DNA synthesis has a significant role in the recombination
process required for AAV TR HP substrate circularization.
Unwinding of DNA, either in conjunction with DNA syn-
thesis or through generation of single-stranded intermediates,
introduces conformational stress on closed double-stranded
DNA molecules, which can be relieved by topoisomerases (20,
30). We tested the role of DNA topoisomerases I and II in
recombination between rAAV TR HP structures by inhibition
with CPT and Etopo, respectively (Fig. 2B). The two intact
GFP control vectors were unaffected by either topoisomerase
inhibitor. In contrast, scAAV-GFPcd was slightly inhibited by
Etopo and strongly inhibited by CPT treatment. This suggests
that topoisomerase I plays an important role in intramolecular
recombination between the open and closed HP ends.
Differential inhibition of concatemerization by drug treat-
ment. The study on intramolecular recombination using
scAAV-GFPcd is independent of the concentration of vector
ends and only assayed recombination between a close-open
combination of TRs carried on the same molecule. Intermo-
lecular recombination assays permitted the measurement of
drug inhibition effects on the open and closed TR HP struc-
tures in the four vector combinations (C-C, O-O, C-O, and
O-C). The cellular factors or activities required for processing
the closed and open TR structure could thus be inferred.
The HU treatment reduced the concatemerization efficiency
of all four combinations of split scAAV vectors to similar levels
(Fig. 4A). Likewise, the effect of Aph on recombination be-
tween specific TR structures closely paralleled the HU treat-
ment (Fig. 4B). It should be noted that C-C combination
showed the greatest sensitivity to these drug treatments. Also,
there appeared to be no preference for specific HP substrates
for recombination under these conditions, which contrast the
results in the absence of drug. This supports the idea that DNA
FIG. 3. The C-C TR combination is the preferred substrate for
concatemerization in HeLa and 293 cells. (A) HEK 293 cells were
coinfected with the indicated pairs of split scAAV vectors, and GFP-
positive cells were counted under a fluorescence microscope at the
indicated times postinfection (see the legend to Fig. 1 for labels).
(B) Cells were coinfected with split scAAV vectors, and GFP-express-
ing cells were quantified by flow cytometry. Experiments were repeated
on HeLa cells with four additional, independently prepared sets of
scAAV vectors (two sets purified and two sets crude lysates of vector
producing cells), with the titer of each determined by infectious center
assay. Identical results were obtained with each set with little differ-
ence between the O-C versus C-O combinations, which were always
intermediate between C-C and O-O (data not shown).
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synthesis is required for recombination between rAAV TR HP
substrates. Moreover, these studies suggest additional process-
ing of closed HP ends and further suggest the potential in-
volvement of , , or ε polymerase complexes.
The role of topoisomerases on each combination of TR HP
structures was also evaluated. Etopo treatment resulted in
significant, but nonspecific, inhibition of each recombination
pair (Fig. 4C). In contrast, the CPT treatment generated a
pattern of HP substrate preference that was opposite to that
seen in the untreated cells (Fig. 4D). The O-O combination
was favored for recombination over the C-C combination by
10-fold in CPT-treated cells. The O-C recombinations were
also consistently lower than O-O under CPT treatment, in
contrast to untreated cells. This suggests that there is a strin-
gent requirement for topoisomerase I in processing closed-end
TR HP structures for both intramolecular and intermolecular
recombination.
The effect of each inhibitor on intermolecular recombina-
tion between O-C pairs of TRs was generally similar in mag-
nitude to the inhibition of intramolecular recombination. This
again is consistent with the hypothesis that intramolecular re-
combination was mechanistically the same as O-C intermolec-
ular recombination but more efficient due to the close prox-
imity of the two ends and the independence from DNA
substrate concentration.
DISCUSSION
We used circularization-dependent and orientation-specific
split scAAV vectors as a model system for the characterization
of recombination between different DNA HP structures. This
virus-based delivery system permitted controlled and quantifi-
able transport of DNA substrates to the nucleus. By taking
advantage of the unique properties of the scAAV genome, we
could control the orientation of the reporter gene segments
between the open and closed TR HP ends. This, in turn,
allowed the measurement and characterization of recombina-
tion events between different kinds of HP structures, repre-
sented by AAV termini. We observed that both the open and
closed HP scAAV ends can serve as substrates for circulariza-
tion and concatemerization. The two TR HP ends are not
equivalent in recombination efficiency or sensitivity to drug
inhibition. Indeed, it was surprising to discover that the joining
of two closed HP ends was more efficient than any combination
involving an open TR in concatemerization. However, this
advantage was lost under conditions of DNA synthesis inhibi-
tion.
Prior to the current study, investigations of recombination
between AAV TR HP substrates had relied on amplification of
the end products in bacteria or by PCR followed by Southern
blot analysis. This approach has limitations (i.e., rearrange-
ment of TR products) but most importantly cannot distinguish
between the different starting substrates (3–5, 24, 33, 35). The
oriented split vectors allowed us to distinguish between starting
HP substrates. In any coinfection, there are four possible com-
binations of TR HPs that can lead to recombination products
(see Fig. 1B). The design of this recombination system allowed
us to specifically measure the four possible combinations in-
dependently (Fig. 3). This includes the highly efficient circu-
FIG. 4. Differential effects of DNA synthesis and topoisomerase inhibitors on specific TR combinations. HeLa cells were treated with the
indicated dosage of drugs 24 h prior to infection with pairs of split vectors (see Fig. 1). Drug treatment was maintained through the duration of
the experiment, and GFP expression was quantified by flow cytometry 24 h postinfection. (A) 20 mM HU; (B) 10 g/ml Aph; (C) 1 M Etopo;
(D) 25 nM CPT. The number of severalfold difference between no drug and drug treatment is indicated.
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larization of monomeric genomes, which can be considered a
competing intramolecular O-C end recombination. While it is
possible that some concatemeric genomes arise through inter-
molecular recombination between these monomeric circles, we
do not expect this to be a major contributor to concatemers
formed within the time frame of our experiments (24 h) (36),
because in vivo data suggest that the generation of concate-
meric products from circles form over weeks (31, 35). From
our studies, the majority of the recombination that takes place
utilizes these HP substrates to form intramolecular products
(97%) (Fig. 2). Despite this very efficient reaction, we were
able to detect intermolecular recombination at high substrate
concentration and to specifically measure the influence of
starting HP substrate on efficiency (i.e., C-C) (Fig. 3). These
studies have provided for the first time the ability to test the
requirement for HP substrate in both intra- and intermolecular
recombination.
The importance of using our reporter system to study the
efficiency of concatemerization is that the four possible com-
binations of TR HP substrates can be quantitatively deter-
mined. To calculate the overall concatemerization efficiency of
any two scAAV vectors used in our study, we can combine the
four measured recombination events that lead to GFP expres-
sion and those that do not but can be inferred statistically.
Total intermolecular recombination efficiency (Etotal) is the
sum of intermolecular recombination efficiencies of all the HP
combinations (Fig. 1C): Etotal  EC-C  EO-O  EC-O  EO-C,
where Etotal is defined as the percentage of the number of
intermolecular recombination events per total number of input
genomes. Given the experimental conditions used in this assay
and based on the measurements of percentage of GFP-ex-
pressing cells for each pair of HP substrates (Fig. 3B, dosage 20
IU/virus/cell), we obtained the following: EC-C  0.75%; EO-O
 0.3%; EC-O  0.45%; EO-C  0.55%. Therefore, the total
efficiency of intermolecular recombination is determined to be
Etotal  2.05% (refer to supplemental material for detailed
calculation). The remainder of the genomes that did not par-
ticipate in concatemerization, but as closely as we can measure
by using scAAV-GFPcd, had formed circles.
While it would be of great interest to examine the structures
arising through recombination between specific TR open and
closed HP substrate ends, the detailed structure of TR junc-
tions between AAV concatemers has been difficult to deter-
mine due to the high GC content and secondary structure of
the TR sequence (22, 34). Our calculations suggest that the
C-C and O-O products comprise less than 1% of the vector
genomes in the nucleus, making direct observation of these
junctions by Southern blotting unlikely. Analysis of AAV TR
HP structures using current methods, such as PCR amplifica-
tion, is highly prone to artifacts. This can be attributed to the
inefficiency of amplification of junctions containing two copies
of the TR compared to that for those with one copy (37; D. M.
McCarty, unpublished data).
Role of host factors. In previous studies, the junctions in
bacterial amplified episomal AAV have been described as one
or two imperfect double-strand copies of the TR carrying var-
ious crossover points (3–5, 24, 33, 35). Although the exact role
E. coli may play in the stable isolation of these junctions is
unknown, eukaryotic cellular activities that would be predicted
to carry out the steps required to form these junctions include
an endonuclease to nick the closed HP, an exonuclease to
create single-stranded regions, DNA polymerase to fill gaps,
and ligase to covalently join the DNA strands. One interpre-
tation of the differential drug inhibition of the various kinds of
recombination is that some are more dependent on specific
processing steps than others. For example, the C-C combina-
tion, which is most affected by both DNA synthesis and topo-
isomerase I inhibition, may be more dependent on gap filling
because this HP must be nicked or otherwise degraded prior to
joining. Alternatively, we note that under DNA synthesis inhi-
bition and consequent G1/S-phase (Aph) or S-phase (HU) cell
cycle arrest, C-C recombination is reduced to the same base
level as the other HP substrate combinations. This raises the
possibility that an alternate pathway may utilize all HP sub-
strates equivalently and that additional pathway(s) may selec-
tively utilize C-C substrates which would result in an overall
increase in recombination products (Fig. 3). Because DNA
replication is tightly coupled and regulated in the cell cycle, the
selective pathway identified by our drug studies may also par-
ticipate in the cell cycle.
We also note that while topoisomerases I and II both appear
to participate in the recombination reactions, the former has a
far greater effect on closed HP ends and the latter appears
nonspecific. It has been proposed that topoisomerase I is in-
volved in Holliday junction-like resolution and in recruiting
recombination proteins to the recombination site (30). Camp-
tothecin binds reversibly to the complex of topoisomerase I
and nicked DNA but not to the free protein or DNA alone,
suggesting that there is a direct enzymatic role for topoiso-
merase I in processing the HP end (7). This raises the inter-
esting possibility that topoisomerase I mediates an efficient
concerted nicking-and-joining reaction using HP substrates, as
has been observed in Tn10 transposition (9) and mammalian
V(D)J recombination (36). While the CPT treatment also ar-
rests cells in the G1/S phase, the C-C recombination is de-
creased to a level below that of either O-O or O-C under these
conditions. This inverse pattern of preference suggests a more
specific requirement for topoisomerase I in the processing of
closed-HP substrates and begins to distinguish a mechanism
for how different HP substrates are utilized by the host cell
recombination machinery.
In a previous study (13), the circularization efficiency of
transfected blunt-end DNA substrate was determined to be
fivefold greater than that of DNA with HP ends in nonlym-
phoid mammalian cells. In a separate study (19), DNA frag-
ments with or without AAV TR sequence at the ends were
introduced into mouse hepatocytes by transfection. This study
concluded that the AAV TR sequence is not required for
circularization and concatemerization. However, the AAV TR
sequence was left blunt rather than in hairpinned structures,
and all the substrate analyzed was delivered by transfection. In
contrast, our results suggest that essentially all AAV TR HP
substrates utilized in this system participate in recombination
events within 24 h of entering the nucleus. It is difficult to
determine if AAV TR HP structures are extremely recombi-
nogenic due to a different route of substrate delivery (viral
versus nonviral) or due to the availability for forming AAV TR
HP conformation. Regardless, our results suggest that the HP
structures can participate efficiently in recombination. In ad-
dition, another recent report has demonstrated the ability of
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scAAV vectors to carry a non-AAV HP substrate efficiently
into cells. This creates a new opportunity to systematically
study the specific role of HP sequence and/or structure on
intra- and intermolecular recombination by viral delivery (X.
Zhu, personal communications).
The efficient and predictable delivery of defined DNA sub-
strates to nuclei using this viral system is likely to have broad
relevance for mammalian DNA recombination. The circular-
ization-dependent and concatemerization-dependent vectors
that we have described will provide an accurate and sensitive
recombination assay for many different cell types (e.g., recom-
bination-deficient cell lines) and animal tissues (e.g., DNA
repair-deficient transgenic animals), leading to new insights
into the role of HP structures in recombination and DNA
damage repair.
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